Skip to main content
. 2020 Dec 7;5(54):eabe0240. doi: 10.1126/sciimmunol.abe0240

Table 1. Patient Demographic and Clinical Characteristics.

Characteristics Outpatients and asymptomatic individuals (n=160) Admitted, non-ICU
(n=35)
Admitted,
ICU
(n=20)
Deceased*
(n=25)
Age, median (IQR) 41 (32-56) 55 (40-71) 44 (37-63) 76 (64-85)
Sex (%) Female 101 (63) 20 (57) 10 (50) 10 (40)
Male 59 (37) 15 (43) 10 (50) 15 (60)
Diagnostic rRT-PCR Ct, median (IQR) 29.7
(21.8-37.3)
30.6
(21.1-35.4)
25.2
(22.5-29.9)
20.4
(16.5-28.8)
Comorbidities,
number of individuals (% present)
Obesity 43 (27 NA) (32) 15 (1 NA) (43) 11 (55) 10 (40)
Hypertension 30 (19) 8 (23) 7 (35) 19 (76)
DM 16 (10) 7 (20) 7 (35) 14 (56)
Symptoms on presentation, N of individuals
(% present)
Cough 93 (58) 27 (77) 17 (85) 15 (60)
Fever 72 (45) 23 (66) 15 (75) 11 (44)
SOB 30 (19) 25 (71) 15 (75) 18 (72)
Myalgia 60 (38) 15 (43) 11 (55) 3 (12)
GI 29 (18) 19 (54) 10 (50) 5 (20)
Fatigue 56 (35) 17 (49) 6 (30) 7 (28)
Chills 29 (18) 10 (29) 8 (40) 3 (12)
Headache 37 (23) 6 (17) 5 (25) 1 (4)
Mechanical ventilation (%) 0 0 11 (55) 15 (60)
Length of hospital stay, median days (IQR) NA 5 (2-8) 17 (9-49) 15 (5-29)
Number of plasma specimens per patient, median (IQR) 1 (1-2) 5 (4-8) 13 (8-21) 8 (3-11)

ICU, intensive care unit; IQR, inter quartile range; rRT-PCR Ct, real-time reverse transcription polymerase chain reaction cycle threshold; NA, not available; DM, diabetes mellitus; SOB, shortness of breath; GI, gastrointestinal. *Of the 25 deceased patients, one, seven, and seventeen were categorized as outpatient, admitted non-ICU, and admitted ICU, respectively. The fourteen individuals that were part of the validation cohort were not included in this table.